Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia
Clinical trial NCT00954122 · COMPLETED
Trial details
- NCT number
- NCT00954122
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-03-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.